Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE
Edouard Bardou‐Jacquet(Inserm), Yves Deugnier(Inserm), Bruno Turlin(Inserm), Andrew D. Clouston(The University of Queensland), Emilie Morandeau(Centre Hospitalier Universitaire de Rennes), Gregory J. Anderson(The University of Queensland), Jeff Morçet(Inserm), Fabrice Lainé(Inserm), Lawrie W. Powell(The University of Queensland), Jeannette L. Dixon(QIMR Berghofer Medical Research Institute), Grant A. Ramm(QIMR Berghofer Medical Research Institute), Louise E. Ramm(QIMR Berghofer Medical Research Institute), Guillaume Bouzillé(Inserm)
Cited by 51
Related Papers
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
|Journal of Biological Chemistry|2001|1.7k
Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
|Hepatology|2011|719
Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.
|Molecular Pharmacology|1993|536
Insulin resistance–associated hepatic iron overload
|Gastroenterology|1999|509